Perkins Capital Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-35,632
| Closed | -$132K | – | 129 |
|
|
2017
Q4 | $132K | Sell |
35,632
-15,681
| -31% | -$58.1K | 0.13% | 99 |
|
|
2017
Q3 | $210K | Sell |
51,313
-816
| -2% | -$3.34K | 0.22% | 83 |
|
|
2017
Q2 | $194K | Buy |
52,129
+4,000
| +8% | +$14.9K | 0.22% | 86 |
|
|
2017
Q1 | $199K | Buy |
48,129
+2,887
| +6% | +$11.9K | 0.21% | 93 |
|
|
2016
Q4 | $195K | Sell |
45,242
-641
| -1% | -$2.76K | 0.21% | 89 |
|
|
2016
Q3 | $451K | Sell |
45,883
-5,350
| -10% | -$52.6K | 0.45% | 72 |
|
|
2016
Q2 | $290K | Sell |
51,233
-692
| -1% | -$3.92K | 0.33% | 75 |
|
|
2016
Q1 | $396K | Sell |
51,925
-11,633
| -18% | -$88.7K | 0.5% | 64 |
|
|
2015
Q4 | $847K | Sell |
63,558
-1,550
| -2% | -$20.7K | 0.91% | 35 |
|
|
2015
Q3 | $1.07M | Sell |
65,108
-2,294
| -3% | -$37.7K | 1.19% | 24 |
|
|
2015
Q2 | $1.51M | Sell |
67,402
-3,865
| -5% | -$86.8K | 1.33% | 20 |
|
|
2015
Q1 | $697K | Buy |
71,267
+89
| +0.1% | +$870 | 0.58% | 63 |
|
|
2014
Q4 | $811K | Sell |
71,178
-6,272
| -8% | -$71.5K | 0.7% | 56 |
|
|
2014
Q3 | $892K | Sell |
77,450
-2,733
| -3% | -$31.5K | 0.75% | 49 |
|
|
2014
Q2 | $1.56M | Sell |
80,183
-1,725
| -2% | -$33.5K | 1.1% | 30 |
|
|
2014
Q1 | $1.47M | Sell |
81,908
-10,567
| -11% | -$190K | 1.03% | 32 |
|
|
2013
Q4 | $977K | Sell |
92,475
-7,458
| -7% | -$78.8K | 0.66% | 60 |
|
|
2013
Q3 | $1.24M | Buy |
99,933
+9,583
| +11% | +$118K | 0.89% | 43 |
|
|
2013
Q2 | $851K | Buy |
+90,350
| New | +$851K | 0.68% | 54 |
|